Some investigations have shown elevated AKT activity to be highly prevalent in high grade, late stage and/or metastatic tumors, and several reports have linked AKT activation with reduced patient survival or tumor radio-resistance [42,43]. Here, AKT1 is linked to metastatic neoplasm.